Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Cancer prevalence in the world has been attributed to exposure to air pollutants. However, spatial analyses utilizing remote sensing data have been limited. This study combined satellite-derived measurements of eight air pollutants (SO2, NO2, CO, HCHO, CH4, PM1, PM10, and AER AI) with machine learning algorithms to analyze the relationship between air pollution and cancer prevalence across all 254...
Glioblastoma (GB), the most aggressive primary brain tumor, is characterized by profound inter- and intratumoral heterogeneity and a highly immunosuppressive tumor microenvironment (TME), both of which contribute to its poor prognosis and resistance to conventional therapies. The dynamic interplay between malignant cells and diverse TME constituents including immune cells, neural elements, and ext...
Preoperatively distinguishing follicular thyroid carcinoma (FTC) from follicular thyroid adenoma (FTA) remains a significant clinical challenge. Curre...
BACKGROUND: Artificial intelligence-based radiomic approaches have been shown to accurately evaluate indeterminate pulmonary nodules. With the expansi...
BACKGROUND: Lentigo maligna (LM) and lentigo maligna melanoma (LMM) are difficult to manage because of their subclinical extension and ill-defined mar...
Chimeric antigen receptor (CAR) T-cell therapy has transformed the management of hematologic malignancies, achieving high remission rates in relapsed ...
Therapeutic resistance remains the principal barrier to durable clinical benefit in oncology, particularly in oncogene-driven malignancies and immune-...
Time-of-flight (ToF) in PET improves image quality by enhancing the signal-to-noise ratio, and recent deep learning (DL)-based ToF (DL-ToF) methods fu...
BACKGROUND: Sinonasal inverted papilloma(SNIP) is a benign tumor with a potential of malignant transformation but has a certain recurrence. OBJECTIVES...
Early detection of lung cancer remains critical for improving patient survival, yet current imaging-based screening methods are costly, invasive, and ...
As artificial intelligence (AI) has been proposed to aid in the clinical management of leukemia, we sought to summarize the most relevant, current lit...
Cells must adopt flexible regulatory strategies to make decisions regarding their fate, including differentiation, apoptosis, or survival in the face ...
Digital breast tomosynthesis (DBT) increases sensitivity and specificity compared to digital mammography (DM) in the early detection of breast cancer....
BACKGROUND AND PURPOSE: The telomerase reverse transcriptase (TERT) gene promoter mutation is a crucial factor for identifying an isocitrate dehydroge...
Breast cancer diagnosis from histopathological images remains a critical yet challenging task due to staining variability, magnification differences, ...
Cell-free DNA in blood originates from fragmented chromatin released by dying cells from both healthy and diseased tissues1,2. These fragments carry r...
Prostate cancer exhibits complex transcriptional heterogeneity that underlies disease progression and therapeutic resistance. We developed an integrat...
Immunotherapy with immune checkpoint blockade (ICB) in epithelial ovarian carcinoma (EOC) shows limited clinical benefit only for a small subset of pa...
Lung adenocarcinoma (LUAD) remains a leading cause of cancer-related mortality worldwide, highlighting the urgent need for non-invasive strategies for...
OBJECTIVE: Soft tissue sarcomas (STS) are a rare and heterogeneous group of tumors that pose a significant challenge for surgical planning. This study...